These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 445447)

  • 1. Competitive binding radioassay for 5-fluorodeoxyuridine 5'-monophosphate in tissues.
    Murinson DS; Anderson T; Schwartz HS; Myers CE; Chabner BA
    Cancer Res; 1979 Jul; 39(7 Pt 1):2471-5. PubMed ID: 445447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
    Washtien WL; Santi DV
    Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.
    Myers CE; Young RC; Chabner BA
    J Clin Invest; 1975 Nov; 56(5):1231-8. PubMed ID: 1184747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive binding radioassay for the determination of 5-fluorodeoxyuridine and 5-fluorodeoxyuridine-5'-monophosphate levels in plasma and tumor tissue.
    Miyata S; Mikami H; Tai M; Hori T; Fujita H
    Jpn J Cancer Res; 1991 Jun; 82(6):742-6. PubMed ID: 1830300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase.
    Moran RG; Spears CP; Heidelberger C
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1456-60. PubMed ID: 108681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
    Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA
    Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nitrocellulose-filter assay for the binary complex of 5-fluorodeoxyuridylate and Lactobacillus casei thymidylate synthetase.
    Ahmed F; Moore MA; Dunlap RB
    Anal Biochem; 1985 Feb; 145(1):151-9. PubMed ID: 3923859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of 5-fluorouracil sensitivity in human tumors.
    Moran RG; Heidelberger C
    Bull Cancer; 1979; 66(1):79-83. PubMed ID: 420950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mammalian tumour thymidylate synthetase by 2'-deoxyuridine 5'-phosphate analogues.
    Rode W; Kulikowski T; Kedzierska B; Shugar D
    Drugs Exp Clin Res; 1986; 12(6-7):545-9. PubMed ID: 3743372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
    Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
    Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P; Connelly K; Cerna I; Mandel HG
    Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
    [No Abstract]   [Full Text] [Related]  

  • 13. On the rational development of a new drug: the example of the fluorinated pyrimidines.
    Heidelberger C
    Cancer Treat Rep; 1981; 65 Suppl 3():3-9. PubMed ID: 7346154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
    Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
    Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
    Johnston PG; Drake JC; Trepel J; Allegra CJ
    Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil.
    Washtien WL
    Mol Pharmacol; 1984 Jan; 25(1):171-7. PubMed ID: 6708932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A direct ligand-binding radioassay for the measurement of methotrexate in tissues and biological fluids.
    Arons E; Rothenberg SP; Costa MD; Fischer C; Iqbal MP
    Cancer Res; 1975 Aug; 35(8):2033-8. PubMed ID: 807320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of periodate and methylamine for the quantitation of intracellular 5-fluoro-2'-deoxyuridine-5'-monophosphate by high-performance liquid chromatography.
    Dreyer R; Cadman E
    J Chromatogr; 1981 Dec; 219(2):273-84. PubMed ID: 6274888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors.
    Van der Wilt CL; Pinedo HM; Smid K; Peters GJ
    Cancer Res; 1992 Sep; 52(18):4922-8. PubMed ID: 1516048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.